Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
My New Book is Now A Best Seller | Order Now My New Book is Now A Best Seller | Order Now

Cholesterol Lowering Drugs to Go Over the Counter

  • May 12, 2004

Analysts believe that with Britain on the verge of clearing over-the-counter sales of a top-selling cholesterol drug, the United States will likely be the next big market as regulators warm to the idea of a switch. The FDA in 2000 rejected the initial bid to move Merck's Mevacor and Bristol-Myers Squibb's Pravachol to nonprescription status because of safety concerns. But the agency has taken a more positive view of prescription-to-OTC switches in recent years, boosting chances for a switch...